Related Experiment Video
Updated: Apr 1, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Association of pentraxin-3 with the severity of rheumatic mitral valve stenosis
Objective:
Inflammation is involved in the pathogenesis of rheumatic mitral valve stenosis (RMVS). Pentraxin-3 (PTX3) indicates the inflammatory state of humans. However, circulating PTX3 levels in patients with RMVS, remain largely unknown. In this study, we investigated whether there is an association between the severity of RMVS and PTX3.
Methods:
All patients diagnosed as rheumatic mitral valvular stenosis between December 2013 and April 2014 were included in the study. We investigated circulating PTX3 and high-sensitivity C-reactive protein (hsCRP) levels in patients with RMVS and healthy controls.
Resuits:
The study population included 72 subjects (41 patients with RMVS and 31 healthy subjects, 56 female) with a mean age of 40 +/- 13 years. Patients with RMVS had higher left atrial diameters than healthy subjects. PTX3 and hsCRP were significantly higher in patients with RMVS when compared to control subjects and this difference was more significant in PTX3 compared to hsCRP (3.37 +/- 1.11 vs 2.86 +/- 0.59, P = 0.014 and 2.36 +/- 1.48 vs. 1.72 +/- 0.73, P = 0.019, respectively). PTX3 was positively correlated with Wilkins score, mitral valvular area, mitral pressure gradient and left atrium diameter.
Conclusions:
We demonstrated that plasma PTX3 and hsCRP levels were increased in patients with RMVS. Compared to hsCRP, PTX3 was more closely related with the severity of mitral valve stenosis. These findings suggest that PTX3 may participate in the pathophysiology of RMVS.
Insights
Elevated Pentraxin-3 (PTX3) levels are associated with rheumatic mitral valve stenosis (RMVS) severity. PTX3 may play a role in RMVS, offering a potential biomarker for this inflammatory heart condition.
Area of Science:
- Cardiology
- Inflammation Research
- Biomarker Discovery
Background:
- Inflammation is implicated in rheumatic mitral valve stenosis (RMVS) pathogenesis.
- Pentraxin-3 (PTX3) is a marker of human inflammatory states.
- Circulating PTX3 levels in RMVS patients are not well understood.
Purpose of the Study:
- To investigate the association between PTX3 levels and RMVS severity.
- To compare PTX3 levels in RMVS patients versus healthy controls.
Main Methods:
- Included 41 RMVS patients and 31 healthy controls.
- Measured circulating PTX3 and high-sensitivity C-reactive protein (hsCRP) levels.
- Correlated PTX3 with clinical severity scores (Wilkins score) and echocardiographic parameters.
Main Results:
- RMVS patients exhibited significantly higher PTX3 and hsCRP levels than controls.
- PTX3 levels were more significantly elevated than hsCRP in RMVS patients.
- PTX3 positively correlated with RMVS severity indicators like Wilkins score and left atrial diameter.
Conclusions:
- Plasma PTX3 and hsCRP levels are increased in RMVS patients.
- PTX3 shows a stronger association with RMVS severity compared to hsCRP.
- PTX3 may be involved in the pathophysiology of RMVS, suggesting its potential as a biomarker.
Related Concept Videos
Mitral Stenosis III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Rheumatic Heart Disease III: Medical Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests

